| Metrics | Details |
|---|---|
| Years | 2020-2035 |
| Base Year | 2025 |
| Market Size | 10100 |
| Regions | North America (United States, Canada, Mexico) |
| Segments | By Type (Synthetic mRNA, Modified mRNA, Unmodified mRNA, Self-amplifying mRNA, Circular mRNA, Purified mRNA), By Application (Vaccines, Cancer Immunotherapy, Protein Replacement Therapy, Gene Editing, Research Applications, Rare Diseases), By Distribution Channels (Direct Sales, Distributors, Online Platforms, Retail Pharmacies, Hospital Pharmacies, Others), By Technology (In vitro Transcription, Enzymatic Synthesis, Lipid Nanoparticle Formulation, Purification Technologies, Polymerase Chain Reaction, Others), By Organization Size (Small, Medium, Large) |
| Players | Moderna Inc., BioNTech SE, Pfizer Inc., Thermo Fisher Scientific Inc., GSK plc, CureVac AG, TriLink BioTechnologies, Danaher Corporation, Agilent Technologies, New England Biolabs, Merck KGaA, Samsung Biologics, Aldevron (A Danaher Company), Bio-Synthesis Inc., GenScript Biotech |
How Will You Befit From our consulting service
